La Prof.ssa Valente e il Prof. Di Fonzo si confrontano sui nuovi target e approcci terapeutici nella malattia di Parkinson.
- WHO. Parkinson disease. https://www.who.int/news-room/fact-sheets/detail/parkinson-disease
- Levin J, Sing N, Melbourne S et al. Safety, tolerability and pharmacokinetics of the oligomer
modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson
model: A randomised, double-blind, placebo-controlled phase 1a trial. EBioMedicine
2022;80:104021
- Bengoa-Vergniory N, Faggiani E, Ramos-Gonzalez P et al. CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson's disease. Nat Commun 2020;11:4885
- Pagan FL, Wilmarth B, Torres-Yaghi Y et al. Long-Term Safety and Clinical Effects of Nilotinib in
Parkinson's Disease. Mov Disord 2021;36:740-9
- Petrucci S, Ginevrino M, Trezzi I et al. GBA-Related Parkinson's Disease: Dissection of Genotype-Phenotype Correlates in a Large Italian Cohort. Mov Disord 2020;35:2106-11
- Kopytova AE, Rychkov GN, Nikolaev MA et al. Ambroxol increases glucocerebrosidase (GCase)
activity and restores GCase translocation in primary patient-derived macrophages in Gaucher
disease and Parkinsonism. Parkinsonism Relat Disord 2021;84:112-21
- Usmani A, Shavarebi F, Hiniker A. The Cell Biology of LRRK2 in Parkinson’s Disease. Mol Cell Biol
2021;41:e00660-20
- Labandeira CM, Fraga-Bau A, Arias Ron D et al. Parkinson’s disease and diabetes mellitus: common mechanisms and treatment repurposing. Neural Regen Res 2022;17:1652-8
- Zeng X, An H, Yu F et al. Benefits of Iron Chelators in the Treatment of Parkinson’s Disease.
Neurochem Res 2021;46:1239-51
- Barker RA, Björklund A, Gash DM et al. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. J Parkinsons Dis 2020;10:875-91
- Doi D, Magotani H, Kikuchi T et al. Pre-clinical study of induced pluripotent stem cell-derived
dopaminergic progenitor cells for Parkinson’s disease. Nat Commun 2020;11:3369
- Schweitzer JS, Song B, Herrington TM et al. Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson’s Disease. N Engl J Med 2020;382:1926-32